Key result
Piretanide was as effective as chlorothiazide in controlling cardiac failure over a three-day period, causing significant diuresis and weight loss with less potassium loss.
Why the study?
Does piretanide improve diuresis and weight loss compared to chlorothiazide in patients with cardiac failure?
Does piretanide improve diuresis and weight loss compared to chlorothiazide in patients with cardiac failure?
Piretanide is an effective diuretic for short-term management of cardiac failure, offering comparable efficacy to chlorothiazide but with less potassium loss.
Supports short-term piretanide use for diuresis in cardiac failure with less potassium loss; leaves open confirmation in larger randomized trials.
Piretanide, a diuretic that acts on the loop of Henle, was used to treat patients with cardiac failure. Over a three-day period it caused a significant dose related diuresis and weight loss. It was as effective as chlorothiazide in the control of cardiac failure and was well tolerated by the patients. Potassium loss was less than occurred with chlorothiazide. Its role in the treatment of cardiac failure requires further study and warrants further investigation. The study also showed that many patients with cardiac failure receive diuretic drugs which are not necessary.
No takes yet. Share an insight, caveat, or question.
Gillies et al. (1980) studied Cardiac failure. Piretanide vs. Chlorothiazide was evaluated on Control of cardiac failure, diuresis, weight loss, and potassium loss. Piretanide was as effective as chlorothiazide in controlling cardiac failure over a three-day period, causing significant diuresis and weight loss with less potassium loss.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: